{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T12:51:09Z","timestamp":1743079869573,"version":"3.40.3"},"publisher-location":"Cham","reference-count":130,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031065651"},{"type":"electronic","value":"9783031065668"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-06566-8_5","type":"book-chapter","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T18:02:43Z","timestamp":1665856963000},"page":"117-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PHLPP Signaling in Immune Cells"],"prefix":"10.1007","author":[{"given":"Gema","family":"Lord\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery J.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan K.","family":"Levings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra C.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"issue":"2","key":"5_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2017.03.080","volume":"486","author":"NP Alamuru-Yellapragada","year":"2017","unstructured":"Alamuru-Yellapragada NP, Vundyala S, Behera S, Parsa KV (2017) LPS depletes PHLPP levels in macrophages through the inhibition of SP1 dependent transcriptional regulation. Biochem Biophys Res Commun 486(2):533\u2013538. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.080","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1189\/jlb.0713360","volume":"95","author":"NP Alamuru","year":"2014","unstructured":"Alamuru NP, Behera S, Butchar JP, Tridandapani S, Kaimal Suraj S, Babu PP, Hasnain SE, Ehtesham NZ, Parsa KV (2014) A novel immunomodulatory function of PHLPP1: inhibition of iNOS via attenuation of STAT1 ser727 phosphorylation in mouse macrophages. J Leukoc Biol 95(5):775\u2013783. https:\/\/doi.org\/10.1189\/jlb.0713360","journal-title":"J Leukoc Biol"},{"issue":"4","key":"5_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/intimm\/dxm014","volume":"19","author":"SE Allan","year":"2007","unstructured":"Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19(4):345\u2013354. https:\/\/doi.org\/10.1093\/intimm\/dxm014","journal-title":"Int Immunol"},{"issue":"7","key":"5_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00125-011-2116-6","volume":"54","author":"F Andreozzi","year":"2011","unstructured":"Andreozzi F, Procopio C, Greco A, Mannino GC, Miele C, Raciti GA, Iadicicco C, Beguinot F, Pontiroli AE, Hribal ML, Folli F, Sesti G (2011) Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia 54(7):1879\u20131887. https:\/\/doi.org\/10.1007\/s00125-011-2116-6","journal-title":"Diabetologia"},{"issue":"5","key":"5_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ni.3390","volume":"17","author":"SA Apostolidis","year":"2016","unstructured":"Apostolidis SA, Rodriguez-Rodriguez N, Suarez-Fueyo A, Dioufa N, Ozcan E, Crispin JC, Tsokos MG, Tsokos GC (2016) Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol 17(5):556\u2013564. https:\/\/doi.org\/10.1038\/ni.3390","journal-title":"Nat Immunol"},{"issue":"1","key":"5_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.0105-2896.2010.00899.x","volume":"235","author":"R Arens","year":"2010","unstructured":"Arens R, Schoenberger SP (2010) Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 235(1):190\u2013205. https:\/\/doi.org\/10.1111\/j.0105-2896.2010.00899.x","journal-title":"Immunol Rev"},{"issue":"2","key":"5_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.molcel.2015.05.030","volume":"59","author":"E Arias","year":"2015","unstructured":"Arias E, Koga H, Diaz A, Mocholi E, Patel B, Cuervo AM (2015) Lysosomal mTORC2\/PHLPP1\/Akt regulate chaperone-mediated autophagy. Mol Cell 59(2):270\u2013284. https:\/\/doi.org\/10.1016\/j.molcel.2015.05.030","journal-title":"Mol Cell"},{"key":"5_CR8","doi-asserted-by":"publisher","unstructured":"Baffi TR, Van AN, Zhao W, Mills GB, Newton AC (2019) Protein Kinase C quality control by phosphatase PHLPP1 unveils loss-of-function mechanism in cancer. Mol Cell 74 (2):378\u2013392 e375. https:\/\/doi.org\/10.1016\/j.molcel.2019.02.018","DOI":"10.1016\/j.molcel.2019.02.018"},{"issue":"4","key":"5_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ng1532","volume":"37","author":"K Basso","year":"2005","unstructured":"Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37(4):382\u2013390. https:\/\/doi.org\/10.1038\/ng1532","journal-title":"Nat Genet"},{"issue":"2","key":"5_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1056\/NEJMc1505689","volume":"373","author":"L Beaugerie","year":"2015","unstructured":"Beaugerie L, Itzkowitz SH (2015) Cancers complicating inflammatory bowel disease. N Engl J Med 373(2):195. https:\/\/doi.org\/10.1056\/NEJMc1505689","journal-title":"N Engl J Med"},{"key":"5_CR11","doi-asserted-by":"publisher","unstructured":"Behera S, Kapadia B, Kain V, Alamuru-Yellapragada NP, Murunikkara V, Kumar ST, Babu PP, Seshadri S, Shivarudraiah P, Hiriyan J, Gangula NR, Maddika S, Misra P, Parsa KVL (2018) ERK1\/2 activated PHLPP1 induces skeletal muscle ER stress through the inhibition of a novel substrate AMPK. Biochim Biophys Acta Mol Basis Dis 1864(5 Pt A):1702\u20131716. https:\/\/doi.org\/10.1016\/j.bbadis.2018.02.019","DOI":"10.1016\/j.bbadis.2018.02.019"},{"issue":"9","key":"5_CR12","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.4049\/jimmunol.172.9.5287","volume":"172","author":"SJ Bensinger","year":"2004","unstructured":"Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, Thompson CB, Burchill MA, Farrar MA, Turka LA (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 172(9):5287\u20135296. https:\/\/doi.org\/10.4049\/jimmunol.172.9.5287","journal-title":"J Immunol"},{"issue":"10","key":"5_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2(10):907\u2013916. https:\/\/doi.org\/10.1038\/ni1001-907","journal-title":"Nat Immunol"},{"issue":"6","key":"5_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.joca.2015.12.014","volume":"24","author":"EW Bradley","year":"2016","unstructured":"Bradley EW, Carpio LR, McGee-Lawrence ME, Castillejo Becerra C, Amanatullah DF, Ta LE, Otero M, Goldring MB, Kakar S, Westendorf JJ (2016) Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis. Osteoarthritis Cartilage 24(6):1021\u20131028. https:\/\/doi.org\/10.1016\/j.joca.2015.12.014","journal-title":"Osteoarthritis Cartilage"},{"issue":"26","key":"5_CR15","doi-asserted-by":"publisher","first-page":"16272","DOI":"10.1074\/jbc.M114.612937","volume":"290","author":"EW Bradley","year":"2015","unstructured":"Bradley EW, Carpio LR, Newton AC, Westendorf JJ (2015) Deletion of the PH-domain and Leucine-Rich Repeat Protein Phosphatase 1 (Phlpp1) increases fibroblast growth factor (Fgf) 18 expression and promotes chondrocyte proliferation. J Biol Chem 290(26):16272\u201316280. https:\/\/doi.org\/10.1074\/jbc.M114.612937","journal-title":"J Biol Chem"},{"issue":"14","key":"5_CR16","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1074\/jbc.M112.423723","volume":"288","author":"EW Bradley","year":"2013","unstructured":"Bradley EW, Carpio LR, Westendorf JJ (2013) Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J Biol Chem 288(14):9572\u20139582. https:\/\/doi.org\/10.1074\/jbc.M112.423723","journal-title":"J Biol Chem"},{"issue":"6","key":"5_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard J, Sierecki E, Gao T, Newton AC (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25(6):917\u2013931. https:\/\/doi.org\/10.1016\/j.molcel.2007.02.017","journal-title":"Mol Cell"},{"key":"5_CR18","doi-asserted-by":"publisher","unstructured":"Chen HH, Handel N, Ngeow J, Muller J, Huhn M, Yang HT, Heindl M, Berbers RM, Hegazy AN, Kionke J, Yehia L, Sack U, Blaser F, Rensing-Ehl A, Reifenberger J, Keith J, Travis S, Merkenschlager A, Kiess W, Wittekind C, Walker L, Ehl S, Aretz S, Dustin ML, Eng C, Powrie F, Uhlig HH (2017) Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol 139(2):607\u2013620 e615. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.059","DOI":"10.1016\/j.jaci.2016.03.059"},{"issue":"2","key":"5_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccr.2011.07.013","volume":"20","author":"M Chen","year":"2011","unstructured":"Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O\u2019Neill A, Castillo-Martin M, Nowak DG, Naguib A, Grace DM, Murn J, Navin N, Atwal GS, Sander C, Gerald WL, Cordon-Cardo C, Newton AC, Carver BS, Trotman LC (2011) Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 20(2):173\u2013186. https:\/\/doi.org\/10.1016\/j.ccr.2011.07.013","journal-title":"Cancer Cell"},{"issue":"4","key":"5_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/eji.201444999","volume":"45","author":"W Chen","year":"2015","unstructured":"Chen W, Konkel JE (2015) Development of thymic Foxp3(+) regulatory T cells: TGF-beta matters. Eur J Immunol 45(4):958\u2013965. https:\/\/doi.org\/10.1002\/eji.201444999","journal-title":"Eur J Immunol"},{"key":"5_CR21","doi-asserted-by":"publisher","unstructured":"Cohen Katsenelson K, Stender JD, Kawashima AT, Lorden G, Uchiyama S, Nizet V, Glass CK, Newton AC (2019) PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife 8. https:\/\/doi.org\/10.7554\/eLife.48609","DOI":"10.7554\/eLife.48609"},{"issue":"3","key":"5_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00125-007-0913-8","volume":"51","author":"D Cozzone","year":"2008","unstructured":"Cozzone D, Frojdo S, Disse E, Debard C, Laville M, Pirola L, Vidal H (2008) Isoform-specific defects of insulin stimulation of Akt\/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Diabetologia 51(3):512\u2013521. https:\/\/doi.org\/10.1007\/s00125-007-0913-8","journal-title":"Diabetologia"},{"issue":"5","key":"5_CR23","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1182\/blood-2006-07-035279","volume":"109","author":"NK Crellin","year":"2007","unstructured":"Crellin NK, Garcia RV, Levings MK (2007) Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109(5):2014\u20132022. https:\/\/doi.org\/10.1182\/blood-2006-07-035279","journal-title":"Blood"},{"key":"5_CR24","doi-asserted-by":"publisher","unstructured":"Cuadrado E, van den Biggelaar M, de Kivit S, Chen YY, Slot M, Doubal I, Meijer A, van Lier RAW, Borst J, Amsen D (2018) Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity. Immunity 48(5):1046\u20131059 e1046. https:\/\/doi.org\/10.1016\/j.immuni.2018.04.008","DOI":"10.1016\/j.immuni.2018.04.008"},{"issue":"3","key":"5_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","volume":"177","author":"JG Cyster","year":"2019","unstructured":"Cyster JG, Allen CDC (2019) B cell responses: cell interaction dynamics and decisions. Cell 177(3):524\u2013540. https:\/\/doi.org\/10.1016\/j.cell.2019.03.016","journal-title":"Cell"},{"issue":"28","key":"5_CR26","doi-asserted-by":"publisher","first-page":"20053","DOI":"10.1074\/jbc.R700006200","volume":"282","author":"NA de Weerd","year":"2007","unstructured":"de Weerd NA, Samarajiwa SA, Hertzog PJ (2007) Type I interferon receptors: biochemistry and biological functions. J Biol Chem 282(28):20053\u201320057. https:\/\/doi.org\/10.1074\/jbc.R700006200","journal-title":"J Biol Chem"},{"issue":"6","key":"5_CR27","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF, Kozma SC, Powell JD (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30(6):832\u2013844. https:\/\/doi.org\/10.1016\/j.immuni.2009.04.014","journal-title":"Immunity"},{"issue":"1","key":"5_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4049\/jimmunol.1801570","volume":"203","author":"Y Ding","year":"2019","unstructured":"Ding Y, Yu A, Tsokos GC, Malek TR (2019) CD25 and protein phosphatase 2A cooperate to enhance IL-2R signaling in human regulatory T cells. J Immunol 203(1):93\u2013104. https:\/\/doi.org\/10.4049\/jimmunol.1801570","journal-title":"J Immunol"},{"issue":"39","key":"5_CR29","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1038\/onc.2013.420","volume":"33","author":"L Dong","year":"2014","unstructured":"Dong L, Jin L, Tseng HY, Wang CY, Wilmott JS, Yosufi B, Yan XG, Jiang CC, Scolyer RA, Zhang XD, Guo ST (2014) Oncogenic suppression of PHLPP1 in human melanoma. Oncogene 33(39):4756\u20134766. https:\/\/doi.org\/10.1038\/onc.2013.420","journal-title":"Oncogene"},{"issue":"5","key":"5_CR30","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1074\/jbc.M113.525501","volume":"289","author":"Y Du","year":"2014","unstructured":"Du Y, Teng X, Wang N, Zhang X, Chen J, Ding P, Qiao Q, Wang Q, Zhang L, Yang C, Yang Z, Chu Y, Du X, Zhou X, Hu W (2014) NF-kappaB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)\/p300 proteins regulate CD59 protein expression to protect cells from complement attack. J Biol Chem 289(5):2711\u20132724. https:\/\/doi.org\/10.1074\/jbc.M113.525501","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"5_CR31","first-page":"127","volume":"10","author":"I Engelberts","year":"1991","unstructured":"Engelberts I, von Asmuth EJ, van der Linden CJ, Buurman WA (1991) The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res 10(1\u20132):127\u2013131","journal-title":"Lymphokine Cytokine Res"},{"issue":"10","key":"5_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","volume":"18","author":"LMR Ferreira","year":"2019","unstructured":"Ferreira LMR, Muller YD, Bluestone JA, Tang Q (2019) Next-generation regulatory T cell therapy. Nat Rev Drug Discov 18(10):749\u2013769. https:\/\/doi.org\/10.1038\/s41573-019-0041-4","journal-title":"Nat Rev Drug Discov"},{"issue":"33","key":"5_CR33","doi-asserted-by":"publisher","first-page":"16551","DOI":"10.1073\/pnas.1904885116","volume":"116","author":"J Fischer","year":"2019","unstructured":"Fischer J, Gutierrez S, Ganesan R, Calabrese C, Ranjan R, Cildir G, Hos NJ, Rybniker J, Wolke M, Fries JWU, Tergaonkar V, Plum G, Antebi A, Robinson N (2019) Leptin signaling impairs macrophage defenses against Salmonella Typhimurium. Proc Natl Acad Sci U S A 116(33):16551\u201316560. https:\/\/doi.org\/10.1073\/pnas.1904885116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"5_CR34","doi-asserted-by":"publisher","first-page":"13947","DOI":"10.1074\/jbc.M117.782896","volume":"292","author":"NR Gangula","year":"2017","unstructured":"Gangula NR, Maddika S (2017) Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1. J Biol Chem 292(34):13947\u201313958. https:\/\/doi.org\/10.1074\/jbc.M117.782896","journal-title":"J Biol Chem"},{"issue":"9","key":"5_CR35","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.4049\/jimmunol.161.9.4803","volume":"161","author":"JJ Gao","year":"1998","unstructured":"Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ (1998) Autocrine\/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J Immunol 161(9):4803\u20134810","journal-title":"J Immunol"},{"issue":"10","key":"5_CR36","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1074\/jbc.M707319200","volume":"283","author":"T Gao","year":"2008","unstructured":"Gao T, Brognard J, Newton AC (2008) The phosphatase PHLPP controls the cellular levels of protein kinase C. J Biol Chem 283(10):6300\u20136311. https:\/\/doi.org\/10.1074\/jbc.M707319200","journal-title":"J Biol Chem"},{"issue":"1","key":"5_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","volume":"18","author":"T Gao","year":"2005","unstructured":"Gao T, Furnari F, Newton AC (2005) PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18(1):13\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2005.03.008","journal-title":"Mol Cell"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","volume":"5","author":"J Geginat","year":"2014","unstructured":"Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, De Simone M, Pagani M, Abrignani S (2014) Plasticity of human CD4 T cell subsets. Front Immunol 5:630. https:\/\/doi.org\/10.3389\/fimmu.2014.00630","journal-title":"Front Immunol"},{"issue":"1","key":"5_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck 3rd","year":"2018","unstructured":"Gieseck RL 3rd, Wilson MS, Wynn TA (2018) Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol 18(1):62\u201376. https:\/\/doi.org\/10.1038\/nri.2017.90","journal-title":"Nat Rev Immunol"},{"issue":"8769","key":"5_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0140-6736(91)91452-z","volume":"338","author":"MP Glauser","year":"1991","unstructured":"Glauser MP, Zanetti G, Baumgartner JD, Cohen J (1991) Septic shock: pathogenesis. Lancet 338(8769):732\u2013736. https:\/\/doi.org\/10.1016\/0140-6736(91)91452-z","journal-title":"Lancet"},{"issue":"6","key":"5_CR41","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1042\/BST20160170","volume":"44","author":"AT Grzechnik","year":"2016","unstructured":"Grzechnik AT, Newton AC (2016) PHLPPing through history: a decade in the life of PHLPP phosphatases. Biochem Soc Trans 44(6):1675\u20131682. https:\/\/doi.org\/10.1042\/BST20160170","journal-title":"Biochem Soc Trans"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fimmu.2012.00245","volume":"3","author":"JM Han","year":"2012","unstructured":"Han JM, Patterson SJ, Levings MK (2012) The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function. Front Immunol 3:245. https:\/\/doi.org\/10.3389\/fimmu.2012.00245","journal-title":"Front Immunol"},{"issue":"19","key":"5_CR43","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","volume":"22","author":"C Haslinger","year":"2004","unstructured":"Haslinger C, Schweifer N, Stilgenbauer S, Dohner H, Lichter P, Kraut N, Stratowa C, Abseher R (2004) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 22(19):3937\u20133949. https:\/\/doi.org\/10.1200\/JCO.2004.12.133","journal-title":"J Clin Oncol"},{"issue":"3","key":"5_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto S, Mathis D, Benoist C (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 205(3):565\u2013574. https:\/\/doi.org\/10.1084\/jem.20071477","journal-title":"J Exp Med"},{"issue":"6913","key":"5_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) A central role for JNK in obesity and insulin resistance. Nature 420(6913):333\u2013336. https:\/\/doi.org\/10.1038\/nature01137","journal-title":"Nature"},{"issue":"6","key":"5_CR46","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140(6):900\u2013917. https:\/\/doi.org\/10.1016\/j.cell.2010.02.034","journal-title":"Cell"},{"issue":"2","key":"5_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J, Borges CM, Townamchai N, Gerriets VA, Rathmell JC, Sharpe AH, Bluestone JA, Turka LA (2015) Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat Immunol 16(2):188\u2013196. https:\/\/doi.org\/10.1038\/ni.3077","journal-title":"Nat Immunol"},{"issue":"5","key":"5_CR48","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/jor.23781","volume":"36","author":"SM Hwang","year":"2018","unstructured":"Hwang SM, Feigenson M, Begun DL, Shull LC, Culley KL, Otero M, Goldring MB, Ta LE, Kakar S, Bradley EW, Westendorf JJ (2018) Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis. J Orthop Res 36(5):1487\u20131497. https:\/\/doi.org\/10.1002\/jor.23781","journal-title":"J Orthop Res"},{"issue":"5","key":"5_CR49","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/or.2011.1201","volume":"25","author":"T Iida","year":"2011","unstructured":"Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H (2011) Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 25(5):1271\u20131277. https:\/\/doi.org\/10.3892\/or.2011.1201","journal-title":"Oncol Rep"},{"issue":"5","key":"5_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10409238.2016.1215288","volume":"51","author":"J Jellusova","year":"2016","unstructured":"Jellusova J, Rickert RC (2016) The PI3K pathway in B cell metabolism. Crit Rev Biochem Mol Biol 51(5):359\u2013378. https:\/\/doi.org\/10.1080\/10409238.2016.1215288","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5_CR51","doi-asserted-by":"publisher","unstructured":"Kawashima AT, Wong C, Lord\u00e9n G, King CC, Lara-Gonzalez P, Desai A, Gingras AC, Newton AC (2021) The PHLPP1 N-terminal extension is a mitotic Cdk1 substrate and controls an interactome switch. Mol Cell Biol 41(3). https:\/\/doi.org\/10.1128\/mcb.00333-20","DOI":"10.1128\/mcb.00333-20"},{"issue":"6","key":"5_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2010.12.002","volume":"33","author":"YM Kerdiles","year":"2010","unstructured":"Kerdiles YM, Stone EL, Beisner DR, McGargill MA, Ch\u2019en IL, Stockmann C, Katayama CD, Hedrick SM (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890\u2013904. https:\/\/doi.org\/10.1016\/j.immuni.2010.12.002","journal-title":"Immunity"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2013.00020","volume":"4","author":"EH Kim","year":"2013","unstructured":"Kim EH, Suresh M (2013) Role of PI3K\/Akt signaling in memory CD8 T cell differentiation. Front Immunol 4:20. https:\/\/doi.org\/10.3389\/fimmu.2013.00020","journal-title":"Front Immunol"},{"issue":"12","key":"5_CR54","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13(12):1057\u20131098. https:\/\/doi.org\/10.1016\/S1473-3099(13)70318-9","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"5_CR55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"YR Lee","year":"2018","unstructured":"Lee YR, Chen M, Pandolfi PP (2018) The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol 19(9):547\u2013562. https:\/\/doi.org\/10.1038\/s41580-018-0015-0","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"5_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nri3728","volume":"14","author":"M Lever","year":"2014","unstructured":"Lever M, Maini PK, van der Merwe PA, Dushek O (2014) Phenotypic models of T cell activation. Nat Rev Immunol 14(9):619\u2013629. https:\/\/doi.org\/10.1038\/nri3728","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5_CR57","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/onc.2012.66","volume":"32","author":"X Li","year":"2013","unstructured":"Li X, Stevens PD, Yang H, Gulhati P, Wang W, Evers BM, Gao T (2013) The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Oncogene 32(4):471\u2013478. https:\/\/doi.org\/10.1038\/onc.2012.66","journal-title":"Oncogene"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fimmu.2012.00228","volume":"3","author":"JJ Limon","year":"2012","unstructured":"Limon JJ, Fruman DA (2012) Akt and mTOR in B cell activation and differentiation. Front Immunol 3:228. https:\/\/doi.org\/10.3389\/fimmu.2012.00228","journal-title":"Front Immunol"},{"issue":"1","key":"5_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X (2016) Post-translational modification control of innate immunity. Immunity 45(1):15\u201330. https:\/\/doi.org\/10.1016\/j.immuni.2016.06.020","journal-title":"Immunity"},{"issue":"24","key":"5_CR60","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1128\/MCB.05799-11","volume":"31","author":"J Liu","year":"2011","unstructured":"Liu J, Stevens PD, Li X, Schmidt MD, Gao T (2011) PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Mol Cell Biol 31(24):4917\u20134927. https:\/\/doi.org\/10.1128\/MCB.05799-11","journal-title":"Mol Cell Biol"},{"issue":"7","key":"5_CR61","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/onc.2008.450","volume":"28","author":"J Liu","year":"2009","unstructured":"Liu J, Weiss HL, Rychahou P, Jackson LN, Evers BM, Gao T (2009) Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 28(7):994\u20131004. https:\/\/doi.org\/10.1038\/onc.2008.450","journal-title":"Oncogene"},{"issue":"2","key":"5_CR62","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","volume":"111","author":"PG Longo","year":"2008","unstructured":"Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG (2008) The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 111(2):846\u2013855. https:\/\/doi.org\/10.1182\/blood-2007-05-089037","journal-title":"Blood"},{"issue":"2","key":"5_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu YC, Yeh WC, Ohashi PS (2008) LPS\/TLR4 signal transduction pathway. Cytokine 42(2):145\u2013151. https:\/\/doi.org\/10.1016\/j.cyto.2008.01.006","journal-title":"Cytokine"},{"key":"5_CR64","doi-asserted-by":"publisher","unstructured":"Lucca LE, Axisa PP, Singer ER, Nolan NM, Dominguez-Villar M, Hafler DA (2019) TIGIT signaling restores suppressor function of Th1 Tregs. JCI Insight 4(3). https:\/\/doi.org\/10.1172\/jci.insight.124427","DOI":"10.1172\/jci.insight.124427"},{"issue":"7587","key":"5_CR65","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature16486","volume":"529","author":"CT Luo","year":"2016","unstructured":"Luo CT, Liao W, Dadi S, Toure A, Li MO (2016) Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature 529(7587):532\u2013536. https:\/\/doi.org\/10.1038\/nature16486","journal-title":"Nature"},{"issue":"1","key":"5_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/cei.13297","volume":"197","author":"KN MacDonald","year":"2019","unstructured":"MacDonald KN, Piret JM, Levings MK (2019) Methods to manufacture regulatory T cells for cell therapy. Clin Exp Immunol 197(1):52\u201363. https:\/\/doi.org\/10.1111\/cei.13297","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"5_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB Signaling: navigating the network. Cell 169(3):381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001","journal-title":"Cell"},{"issue":"1","key":"5_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","volume":"281","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Barajon I, Garlanda C (2018) IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev 281(1):57\u201361. https:\/\/doi.org\/10.1111\/imr.12614","journal-title":"Immunol Rev"},{"issue":"11","key":"5_CR69","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555. https:\/\/doi.org\/10.1016\/s1471-4906(02)02302-5","journal-title":"Trends Immunol"},{"issue":"4","key":"5_CR70","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1073\/pnas.0910292107","volume":"107","author":"S Masubuchi","year":"2010","unstructured":"Masubuchi S, Gao T, O\u2019Neill A, Eckel-Mahan K, Newton AC, Sassone-Corsi P (2010) Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock. Proc Natl Acad Sci U S A 107(4):1642\u20131647. https:\/\/doi.org\/10.1073\/pnas.0910292107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"5_CR71","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1186\/1471-2350-8-S1-S16","volume":"8","author":"JB Meigs","year":"2007","unstructured":"Meigs JB, Manning AK, Fox CS, Florez JC, Liu C, Cupples LA, Dupuis J (2007) Genome-wide association with diabetes-related traits in the framingham heart study. BMC Med Genet 8(Suppl 1):S16. https:\/\/doi.org\/10.1186\/1471-2350-8-S1-S16","journal-title":"BMC Med Genet"},{"issue":"4","key":"5_CR72","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.109.215020","volume":"107","author":"S Miyamoto","year":"2010","unstructured":"Miyamoto S, Purcell NH, Smith JM, Gao T, Whittaker R, Huang K, Castillo R, Glembotski CC, Sussman MA, Newton AC, Brown JH (2010) PHLPP-1 negatively regulates Akt activity and survival in the heart. Circ Res 107(4):476\u2013484. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.215020","journal-title":"Circ Res"},{"issue":"9","key":"5_CR73","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrmicro955","volume":"2","author":"DM Monack","year":"2004","unstructured":"Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2(9):747\u2013765. https:\/\/doi.org\/10.1038\/nrmicro955","journal-title":"Nat Rev Microbiol"},{"issue":"5167","key":"5_CR74","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264(5167):1918\u20131921. https:\/\/doi.org\/10.1126\/science.8009221","journal-title":"Science"},{"issue":"6","key":"5_CR75","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140(6):871\u2013882. https:\/\/doi.org\/10.1016\/j.cell.2010.02.029","journal-title":"Cell"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pharmtox-011112-140338","volume":"54","author":"AC Newton","year":"2014","unstructured":"Newton AC, Trotman LC (2014) Turning off AKT: PHLPP as a drug target. Annu Rev Pharmacol Toxicol 54:537\u2013558. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140338","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"5_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/2159-8290.CD-14-1113","volume":"5","author":"DG Nowak","year":"2015","unstructured":"Nowak DG, Cho H, Herzka T, Watrud K, DeMarco DV, Wang VM, Senturk S, Fellmann C, Ding D, Beinortas T, Kleinman D, Chen M, Sordella R, Wilkinson JE, Castillo-Martin M, Cordon-Cardo C, Robinson BD, Trotman LC (2015) MYC Drives Pten\/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discov 5(6):636\u2013651. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1113","journal-title":"Cancer Discov"},{"issue":"6","key":"5_CR78","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1083\/jcb.201902048","volume":"218","author":"DG Nowak","year":"2019","unstructured":"Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D\u2019Andrea VD, Lee MF, Swamynathan MM, Casanova-Salas I, Jibilian MC, Buckholtz CL, Ambrico AJ, Pan CH, Wilkinson JE, Newton AC, Trotman LC (2019) The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. J Cell Biol 218(6):1943\u20131957. https:\/\/doi.org\/10.1083\/jcb.201902048","journal-title":"J Cell Biol"},{"issue":"2","key":"5_CR79","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1742-4658.2012.08537.x","volume":"280","author":"AK O'Neill","year":"2013","unstructured":"O\u2019Neill AK, Niederst MJ, Newton AC (2013) Suppression of survival signalling pathways by the phosphatase PHLPP. FEBS J 280(2):572\u2013583. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08537.x","journal-title":"FEBS J"},{"issue":"4","key":"5_CR80","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1189\/jlb.69.4.598","volume":"69","author":"Y Ohmori","year":"2001","unstructured":"Ohmori Y, Hamilton TA (2001) Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 69(4):598\u2013604","journal-title":"J Leukoc Biol"},{"issue":"4","key":"5_CR81","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/0008-5472.CAN-07-3105","volume":"68","author":"P Ouillette","year":"2008","unstructured":"Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN (2008) Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 68(4):1012\u20131021. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3105","journal-title":"Cancer Res"},{"issue":"7","key":"5_CR82","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.1884","volume":"11","author":"W Ouyang","year":"2010","unstructured":"Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11(7):618\u2013627. https:\/\/doi.org\/10.1038\/ni.1884","journal-title":"Nat Immunol"},{"issue":"7425","key":"5_CR83","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11581","volume":"491","author":"W Ouyang","year":"2012","unstructured":"Ouyang W, Liao W, Luo CT, Yin N, Huse M, Kim MV, Peng M, Chan P, Ma Q, Mo Y, Meijer D, Zhao K, Rudensky AY, Atwal G, Zhang MQ, Li MO (2012) Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491(7425):554\u2013559. https:\/\/doi.org\/10.1038\/nature11581","journal-title":"Nature"},{"issue":"20","key":"5_CR84","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","volume":"328","author":"JE Parrillo","year":"1993","unstructured":"Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328(20):1471\u20131477. https:\/\/doi.org\/10.1056\/NEJM199305203282008","journal-title":"N Engl J Med"},{"issue":"10","key":"5_CR85","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.4049\/jimmunol.1002126","volume":"186","author":"SJ Patterson","year":"2011","unstructured":"Patterson SJ, Han JM, Garcia R, Assi K, Gao T, O\u2019Neill A, Newton AC, Levings MK (2011) Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J Immunol 186(10):5533\u20135537. https:\/\/doi.org\/10.4049\/jimmunol.1002126","journal-title":"J Immunol"},{"issue":"10","key":"5_CR86","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.4049\/jimmunol.177.10.6598","volume":"177","author":"DT Patton","year":"2006","unstructured":"Patton DT, Garden OA, Pearce WP, Clough LE, Monk CR, Leung E, Rowan WC, Sancho S, Walker LS, Vanhaesebroeck B, Okkenhaug K (2006) Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177(10):6598\u20136602. https:\/\/doi.org\/10.4049\/jimmunol.177.10.6598","journal-title":"J Immunol"},{"issue":"6","key":"5_CR87","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/eji.201646795","volume":"47","author":"SD Pauls","year":"2017","unstructured":"Pauls SD, Marshall AJ (2017) Regulation of immune cell signaling by SHIP1: a phosphatase, scaffold protein, and potential therapeutic target. Eur J Immunol 47(6):932\u2013945. https:\/\/doi.org\/10.1002\/eji.201646795","journal-title":"Eur J Immunol"},{"issue":"11","key":"5_CR88","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1158\/0008-5472.CAN-07-0877","volume":"67","author":"M Qiao","year":"2007","unstructured":"Qiao M, Iglehart JD, Pardee AB (2007) Metastatic potential of 21T human breast cancer cells depends on Akt\/protein kinase B activation. Cancer Res 67(11):5293\u20135299. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0877","journal-title":"Cancer Res"},{"issue":"4","key":"5_CR89","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molcel.2010.03.017","volume":"38","author":"M Qiao","year":"2010","unstructured":"Qiao M, Wang Y, Xu X, Lu J, Dong Y, Tao W, Stein J, Stein GS, Iglehart JD, Shi Q, Pardee AB (2010) Mst1 is an interacting protein that mediates PHLPPs\u2019 induced apoptosis. Mol Cell 38(4):512\u2013523. https:\/\/doi.org\/10.1016\/j.molcel.2010.03.017","journal-title":"Mol Cell"},{"issue":"3","key":"5_CR90","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA (2020) Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol 20(3):158\u2013172. https:\/\/doi.org\/10.1038\/s41577-019-0232-6","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"5_CR91","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.1073\/pnas.111164198","volume":"98","author":"CV Ramana","year":"2001","unstructured":"Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR (2001) Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 98(12):6674\u20136679. https:\/\/doi.org\/10.1073\/pnas.111164198","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3389\/fimmu.2019.02127","volume":"10","author":"T Ran","year":"2019","unstructured":"Ran T, Zhang Y, Diao N, Geng S, Chen K, Lee C, Li L (2019) Enhanced neutrophil immune homeostasis due to deletion of PHLPP. Front Immunol 10:2127. https:\/\/doi.org\/10.3389\/fimmu.2019.02127","journal-title":"Front Immunol"},{"issue":"38","key":"5_CR93","doi-asserted-by":"publisher","first-page":"E3957","DOI":"10.1073\/pnas.1404221111","volume":"111","author":"G Reyes","year":"2014","unstructured":"Reyes G, Niederst M, Cohen-Katsenelson K, Stender JD, Kunkel MT, Chen M, Brognard J, Sierecki E, Gao T, Nowak DG, Trotman LC, Glass CK, Newton AC (2014) Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Proc Natl Acad Sci U S A 111(38):E3957-3965. https:\/\/doi.org\/10.1073\/pnas.1404221111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5_CR94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4049\/jimmunol.1401145","volume":"194","author":"M Rossetti","year":"2015","unstructured":"Rossetti M, Spreafico R, Saidin S, Chua C, Moshref M, Leong JY, Tan YK, Thumboo J, van Loosdregt J, Albani S (2015) Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. J Immunol 194(1):113\u2013124. https:\/\/doi.org\/10.4049\/jimmunol.1401145","journal-title":"J Immunol"},{"issue":"4","key":"5_CR95","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/s0006-291x(03)01049-0","volume":"306","author":"S Sakaguchi","year":"2003","unstructured":"Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A, Honda K, Taniguchi T (2003) Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 306(4):860\u2013866. https:\/\/doi.org\/10.1016\/s0006-291x(03)01049-0","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"5_CR96","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","volume":"21","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21(10):1105\u20131111. https:\/\/doi.org\/10.1093\/intimm\/dxp095","journal-title":"Int Immunol"},{"issue":"3","key":"5_CR97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/SHK.0b013e318262c4b0","volume":"38","author":"R Salomao","year":"2012","unstructured":"Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M (2012) Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38(3):227\u2013242. https:\/\/doi.org\/10.1097\/SHK.0b013e318262c4b0","journal-title":"Shock"},{"issue":"22","key":"5_CR98","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O\u2019Connor E, Shokat KM, Fisher AG, Merkenschlager M (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105(22):7797\u20137802. https:\/\/doi.org\/10.1073\/pnas.0800928105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","volume":"38","author":"PA Savage","year":"2020","unstructured":"Savage PA, Klawon DEJ, Miller CH (2020) regulatory T cell development. Annu Rev Immunol 38:421\u2013453. https:\/\/doi.org\/10.1146\/annurev-immunol-100219-020937","journal-title":"Annu Rev Immunol"},{"key":"5_CR100","doi-asserted-by":"publisher","unstructured":"Sharabi A, Li H, Kasper IR, Pan W, Meidan E, Tsokos MG, Moulton VR, Tsokos GC (2019) PP2A enables IL-2 signaling by preserving IL-2Rbeta chain expression during Treg development. JCI Insight 5.https:\/\/doi.org\/10.1172\/jci.insight.126294","DOI":"10.1172\/jci.insight.126294"},{"issue":"10","key":"5_CR101","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500845","volume":"1","author":"MD Sharma","year":"2015","unstructured":"Sharma MD, Shinde R, McGaha TL, Huang L, Holmgaard RB, Wolchok JD, Mautino MR, Celis E, Sharpe AH, Francisco LM, Powell JD, Yagita H, Mellor AL, Blazar BR, Munn DH (2015) The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment. Sci Adv 1(10):e1500845. https:\/\/doi.org\/10.1126\/sciadv.1500845","journal-title":"Sci Adv"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3389\/fimmu.2019.02716","volume":"10","author":"H Shi","year":"2019","unstructured":"Shi H, Chi H (2019) Metabolic control of treg cell stability, plasticity, and tissue-specific heterogeneity. Front Immunol 10:2716. https:\/\/doi.org\/10.3389\/fimmu.2019.02716","journal-title":"Front Immunol"},{"issue":"11","key":"5_CR103","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116(11):3015\u20133025. https:\/\/doi.org\/10.1172\/JCI28898","journal-title":"J Clin Invest"},{"issue":"2","key":"5_CR104","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ni.3076","volume":"16","author":"S Shrestha","year":"2015","unstructured":"Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H (2015) Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol 16(2):178\u2013187. https:\/\/doi.org\/10.1038\/ni.3076","journal-title":"Nat Immunol"},{"issue":"24","key":"5_CR105","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1021\/bi500428j","volume":"53","author":"E Sierecki","year":"2014","unstructured":"Sierecki E, Newton AC (2014) Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase. Biochemistry 53(24):3971\u20133981. https:\/\/doi.org\/10.1021\/bi500428j","journal-title":"Biochemistry"},{"issue":"19","key":"5_CR106","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1021\/jm100331d","volume":"53","author":"E Sierecki","year":"2010","unstructured":"Sierecki E, Sinko W, McCammon JA, Newton AC (2010) Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening. J Med Chem 53(19):6899\u20136911. https:\/\/doi.org\/10.1021\/jm100331d","journal-title":"J Med Chem"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2012.00244","volume":"3","author":"DR Soond","year":"2012","unstructured":"Soond DR, Slack EC, Garden OA, Patton DT, Okkenhaug K (2012) Does the PI3K pathway promote or antagonize regulatory T cell development and function? Front Immunol 3:244. https:\/\/doi.org\/10.3389\/fimmu.2012.00244","journal-title":"Front Immunol"},{"issue":"1","key":"5_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","volume":"19","author":"M Spite","year":"2014","unstructured":"Spite M, Claria J, Serhan CN (2014) Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 19(1):21\u201336. https:\/\/doi.org\/10.1016\/j.cmet.2013.10.006","journal-title":"Cell Metab"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227\u2013264. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.227","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"5_CR110","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","volume":"40","author":"MA Sugimoto","year":"2019","unstructured":"Sugimoto MA, Vago JP, Perretti M, Teixeira MM (2019) Mediators of the resolution of the inflammatory response. Trends Immunol 40(3):212\u2013227. https:\/\/doi.org\/10.1016\/j.it.2019.01.007","journal-title":"Trends Immunol"},{"issue":"12","key":"5_CR111","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/leu.2010.201","volume":"24","author":"M Suljagic","year":"2010","unstructured":"Suljagic M, Laurenti L, Tarnani M, Alam M, Malek SN, Efremov DG (2010) Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells. Leukemia 24(12):2063\u20132071. https:\/\/doi.org\/10.1038\/leu.2010.201","journal-title":"Leukemia"},{"issue":"27","key":"5_CR112","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1073\/pnas.0704853104","volume":"104","author":"T Tarasenko","year":"2007","unstructured":"Tarasenko T, Kole HK, Chi AW, Mentink-Kane MM, Wynn TA, Bolland S (2007) T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1\/Th2 and cytotoxic responses. Proc Natl Acad Sci U S A 104(27):11382\u201311387. https:\/\/doi.org\/10.1073\/pnas.0704853104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.intimp.2016.02.034","volume":"34","author":"DC Teng","year":"2016","unstructured":"Teng DC, Sun J, An YQ, Hu ZH, Liu P, Ma YC, Han B, Shi Y (2016) Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression. Int Immunopharmacol 34:229\u2013234. https:\/\/doi.org\/10.1016\/j.intimp.2016.02.034","journal-title":"Int Immunopharmacol"},{"issue":"16","key":"5_CR114","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1128\/mcb.20.16.6084-6094.2000","volume":"20","author":"EY Tsai","year":"2000","unstructured":"Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE (2000) A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 20(16):6084\u20136094. https:\/\/doi.org\/10.1128\/mcb.20.16.6084-6094.2000","journal-title":"Mol Cell Biol"},{"issue":"1","key":"5_CR115","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.gene.2013.05.015","volume":"527","author":"A Turki","year":"2013","unstructured":"Turki A, Mahjoub T, Mtiraoui N, Abdelhedi M, Frih A, Almawi WY (2013) Association of POL1, MALT1, MC4R, PHLPP and DSEL single nucleotide polymorphisms in chromosome 18q region with type 2 diabetes in Tunisians. Gene 527(1):243\u2013247. https:\/\/doi.org\/10.1016\/j.gene.2013.05.015","journal-title":"Gene"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3389\/fimmu.2017.01368","volume":"8","author":"E Uribe-Querol","year":"2017","unstructured":"Uribe-Querol E, Rosales C (2017) Control of phagocytosis by microbial pathogens. Front Immunol 8:1368. https:\/\/doi.org\/10.3389\/fimmu.2017.01368","journal-title":"Front Immunol"},{"issue":"7","key":"5_CR117","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523\u2013532. https:\/\/doi.org\/10.1038\/nri2343","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5_CR118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","volume":"20","author":"KL Wallace","year":"2014","unstructured":"Wallace KL, Zheng LB, Kanazawa Y, Shih DQ (2014) Immunopathology of inflammatory bowel disease. World J Gastroenterol 20(1):6\u201321. https:\/\/doi.org\/10.3748\/wjg.v20.i1.6","journal-title":"World J Gastroenterol"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.0105-2896.2005.00218.x","volume":"204","author":"J Wang","year":"2005","unstructured":"Wang J, Fu YX (2005) Tumor necrosis factor family members and inflammatory bowel disease. Immunol Rev 204:144\u2013155. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00218.x","journal-title":"Immunol Rev"},{"issue":"1","key":"5_CR120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/eji.200636435","volume":"37","author":"J Wang","year":"2007","unstructured":"Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37(1):129\u2013138. https:\/\/doi.org\/10.1002\/eji.200636435","journal-title":"Eur J Immunol"},{"issue":"22","key":"5_CR121","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M111.237081","volume":"286","author":"NA Warfel","year":"2011","unstructured":"Warfel NA, Niederst M, Stevens MW, Brennan PM, Frame MC, Newton AC (2011) Mislocalization of the E3 ligase, beta-transducin repeat-containing protein 1 (beta-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. J Biol Chem 286(22):19777\u201319788. https:\/\/doi.org\/10.1074\/jbc.M111.237081","journal-title":"J Biol Chem"},{"key":"5_CR122","doi-asserted-by":"publisher","unstructured":"Wen YA, Li X, Goretsky T, Weiss HL, Barrett TA, Gao T (2015) Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis. Biochim Biophys Acta 1852 (10 Pt A):2013\u20132023. https:\/\/doi.org\/10.1016\/j.bbadis.2015.07.012","DOI":"10.1016\/j.bbadis.2015.07.012"},{"issue":"3","key":"5_CR123","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/10409238.2016.1143913","volume":"51","author":"N Wlodarchak","year":"2016","unstructured":"Wlodarchak N, Xing Y (2016) PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol 51(3):162\u2013184. https:\/\/doi.org\/10.3109\/10409238.2016.1143913","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"6","key":"5_CR124","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","volume":"120","author":"JA Woyach","year":"2012","unstructured":"Woyach JA, Johnson AJ, Byrd JC (2012) The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood 120(6):1175\u20131184. https:\/\/doi.org\/10.1182\/blood-2012-02-362624","journal-title":"Blood"},{"key":"5_CR125","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/623759","volume":"2014","author":"B Yang","year":"2014","unstructured":"Yang B, Kang H, Fung A, Zhao H, Wang T, Ma D (2014) The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm 2014:623759. https:\/\/doi.org\/10.1155\/2014\/623759","journal-title":"Mediators Inflamm"},{"issue":"4","key":"5_CR126","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1006\/bbrc.2001.5883","volume":"288","author":"X Ye","year":"2001","unstructured":"Ye X, Liu SF (2001) Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat. Biochem Biophys Res Commun 288(4):927\u2013932. https:\/\/doi.org\/10.1006\/bbrc.2001.5883","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"5_CR127","doi-asserted-by":"publisher","first-page":"31863","DOI":"10.1074\/jbc.M205544200","volume":"277","author":"X Ye","year":"2002","unstructured":"Ye X, Liu SF (2002) Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation. J Biol Chem 277(35):31863\u201331870. https:\/\/doi.org\/10.1074\/jbc.M205544200","journal-title":"J Biol Chem"},{"issue":"2","key":"5_CR128","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbamcr.2006.09.013","volume":"1773","author":"X Ye","year":"2007","unstructured":"Ye X, Liu SF (2007) Lipopolysaccharide causes Sp1 protein degradation by inducing a unique trypsin-like serine protease in rat lungs. Biochim Biophys Acta 1773(2):243\u2013253. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.09.013","journal-title":"Biochim Biophys Acta"},{"key":"5_CR129","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coi.2017.04.005","volume":"46","author":"H Zeng","year":"2017","unstructured":"Zeng H, Chi H (2017) mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr Opin Immunol 46:103\u2013111. https:\/\/doi.org\/10.1016\/j.coi.2017.04.005","journal-title":"Curr Opin Immunol"},{"issue":"7459","key":"5_CR130","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H (2013) mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499(7459):485\u2013490. https:\/\/doi.org\/10.1038\/nature12297","journal-title":"Nature"}],"container-title":["Current Topics in Microbiology and Immunology","PI3K and AKT Isoforms in Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-06566-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T13:38:48Z","timestamp":1678282728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-06566-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031065651","9783031065668"],"references-count":130,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-06566-8_5","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"type":"print","value":"0070-217X"},{"type":"electronic","value":"2196-9965"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 October 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}